We have studied catabolite gene activator protein (CAP) activation at the araBAD promoter, p BAD , in the absence of DNA looping. We ruled out the two most plausible indirect activation mechanisms: CAP-induced folding of upstream DNA back upon RNA polymerase, and CAP-induced stabilization of AraC binding to DNA. Therefore, a direct CAP-RNA polymerase interaction seemed likely. We sought and found CAP mutants defective in transcription activation at p BAD that retained normal DNA binding affinity. Some mutations altered residues in the interval from positions 150 to 164 that includes CAP activating region 1 (AR1), which has been shown to contact RNA polymerase at a number of promoters. Unexpectedly, additional mutations were found that altered residues in the region between positions 46 and 68 and at position 133. This includes the region known as activating region 3 (AR3). Mutations from both groups also affect the araFGH and rhaBAD promoters.
The presence of multiple activators permits a promoter to respond to multiple environmental cues. The way in which several activators work together is an important question in the study of transcription regulation. The araBAD promoter in Escherichia coli is regulated by two transcription factors, AraC and catabolite gene activator protein (CAP) (13) . The main activator protein, AraC, binds to two direct-repeat half-sites that partially overlap the Ϫ35 region of the promoter (8, 32) . The second activator, CAP, has a binding site centered at position Ϫ93.5 (15) . The mechanisms of transcription activation by these two proteins have been studied extensively (5, 10, 32, 38) .
AraC protein is composed of a dimerization domain and a DNA binding domain (7) . In the absence of arabinose, the dimeric AraC protein binds to the upstream araO 2 half-site and the downstream araI 1 half-site and forms a DNA loop to repress transcription (9, 26) (Fig. 1) . The presence of arabinose induces conformational changes in AraC that lead it to bind to two adjacent half-sites, araI 1 and araI 2 (24, 26) . When bound at araI 1 and araI 2 , AraC helps RNA polymerase to bind to the araBAD promoter, p BAD , and also accelerates open-complex formation (38) .
CAP is the sole activator at two classes of simple E. coli promoters. At class I promoters, where CAP binds at position Ϫ61.5 or further upstream, amino acids 156 to 164 of CAP have been shown to be essential for transcription activation (2, 12, 40) . This activating region, activating region 1 (AR1), directly contacts the alpha subunit of RNA polymerase (10, 19) . At class II promoters, where the CAP binding site is centered at position Ϫ41.5, AR1 and amino acids 19, 21, and 101, which constitute activating region 2 (AR2), were both found to interact with the alpha subunit of RNA polymerase (5, 29) . Also, amino acids 52 to 58, a region known as activating region 3 (AR3), lie close to the sigma subunit of RNA polymerase (5, 21, 37) . In wild-type CAP, AR3 plays little or no role in transcription activation; however, substitution of amino acid 52 can result in increased transcription activation, presumably by creating a new, nonnative interaction between AR3 and sigma (5) .
The role of CAP in systems with multiple activators has also been studied. At some promoters where another activator protein is bound between CAP and RNA polymerase, the AR1 region of the upstream CAP has been shown to be involved in transcription activation (6, 23) . Apparently, CAP can still contact RNA polymerase even though the two are separated by the third protein. CAP may also act as a structural protein by bending DNA about 90°. It has been argued that this sharp bend may facilitate the binding of upstream DNA to the backside of RNA polymerase (4). CAP-induced bending has been shown to modulate the location of binding of the primary activator MalT to trigger transcription activation in the malK promoter (33) .
CAP activates ara p BAD in at least two ways. Previous studies have established that one role of CAP is to break the loop formed by AraC in the absence of arabinose, and thus CAP "activates" transcription by relieving repression (27) . CAP also activates in a loop-independent way (15, 25, 36) . When the upstream AraC half-site araO 2 was deleted to prevent DNA looping, CAP still substantially activated p BAD (15) . Although CAP activation requires the presence of AraC protein, sensitive in vitro studies did not detect any cooperative binding between CAP and AraC (16, 37a) , and in a minicircle assay, CAP actually slightly destabilized AraC binding (27) .
The loop-independent activation by CAP at ara p BAD can be explained if CAP directly contacts RNA polymerase. A possible determinant on CAP for this interaction is AR1, since it has been shown to contact RNA polymerase at a large number of promoters. A previous study with an AR1 mutation, H159L, of CAP however, did not detect any effect at p BAD (37) , even though this mutation strongly disrupted the transcription activation of CAP at both class I and class II promoters. This finding left it unclear how CAP stimulates ara p BAD .
In this study, we first established that CAP activates the p BAD promoter when DNA looping is impossible. We also showed in in vivo experiments that CAP does not activate transcription by stabilizing AraC binding to the promoter. We then screened for CAP mutants defective in transcription activation and found mutants with amino acid changes in AR1 and in a region overlapping but not coincident with AR3. Our results suggest that CAP directly interacts with RNA polymerase to activate transcription at the araBAD promoter.
MATERIALS AND METHODS
General methods, culture media, and conditions. General methods were used as described previously (34) . For the ␤-galactosidase assay and in vivo footprinting, cells were grown in minimal medium, which includes M10 salts, 0.4% glycerol, 10 g of thiamine per ml, 40 g of leucine per ml, 0.2% Casamino Acids, and, when added, 0.2% arabinose or L-rhamnose. The ␤-galactosidase assay was performed as described previously (11) . For screening CAP mutants, the indicator plates contained 25.5 mg of antibiotic medium 2 (Difco) per ml, 50 g of tetrazolium per ml, and 1% lactose. (32) . The sequence of araI 1 *, is 5Ј-TAGCATTTTTATCCTGA-3Ј. p10 and p10ϩCAP were subsequently cloned into the pRS415 plasmid to drive lacZYA reporter genes (35) , and they are named pXZ36 and pXZ51. pXZ23 is a derivative of p10ϩCAP with two upstream CAP binding sites separated by 4 bp, centered at positions Ϫ93.5 and Ϫ108.5, so that the two CAP molecules bind to opposite faces of the DNA.
pXZ59 contains a class I CAP-dependent promoter, CCϩ20pmelR, with its CAP binding site replaced with the ara p BAD CAP site (2). pXZ9 carries CCpmelR, which is a class II CAP-dependent promoter (2) . Both were made by inserting synthesized DNA fragments containing the promoter sequences into pTAP4 plasmids to drive lacZ reporter genes (32) . pGBO21B expresses the AraC DNA binding domain (7) . pGBO21B was digested with PstI and NcoI to delete the AraC gene, which was replaced with the wild-type CAP gene cloned by PCR from the chromosomal template. The new plasmid-expressing CAP protein is named pXZ29. Its sequence was verified by sequencing.
In vivo DMS footprinting. Cells (10 ml) were grown at 37°C in 125-ml flasks to an optical density at 550 nm of 0.8 to 1.0. Dimethyl sulfate (DMS) (10 l) was directly added to the flask, and the cell culture was shaken for 2 min at 37°C. The culture was transferred to an ice-cold centrifuge tube and centrifuged at 1,000 ϫ g for 5 min at 4°C. Plasmid DNA was isolated from the cell pellet and dissolved in 70 l of distilled H 2 O dH 2 O plus 10 l of piperidine. The solution was incubated at 90°C for 30 min, extracted with 1 ml of 1-butanol, and centrifuged at 15,000 ϫ g for 15 min. The plasmid pellet was rinsed with 70% ethanol, dried, and resuspended in 15 l of distilled H 2 O. A PCR amplification was carried out in a 10-l reaction mixture with only one 32 P-labeled oligonucleotide primer. For p10, the primer was 5Ј-AATAGGCGTATCACGAGGCCC-3Ј. For p10ϩCAP, the primer was 5Ј-TTATTTGCACGGCGTCACACTTT-3Ј. The reaction mixture contained 7 l of piperidine-treated plasmid, 0.5 U of Taq DNA polymerase, 3 ng of 32 P-labeled oligonucleotide primer, 10 M dATP, 10 M dCTP, 10
M dTTP, 20 M dGTP, 10 mM MgCl 2 , and 50 mM Tris-HCl (pH 9). The cycle parameters were 94°C for 1 min, 60°C for 1 min, and 65°C for 1 min, repeated for 29 cycles. The reaction products were run on a 6% denaturing polyacrylamide sequencing gel. Random mutagenesis and screening of CAP. The DNA fragment containing the CAP gene was amplified by PCR with primers 5Ј-TCATCCGCCAAAACA GCC-3Ј and 5Ј-AATTAATCATCCGGCTCG-3Ј. Mutations were generated due to the high error rate of Taq DNA polymerase. The PCR conditions were the same as those described by Zhou et al. (41) , and the 100-l PCR mixture contained 50 mM KCl, 20 mM Tris-HCl (pH 8.0), 1.5 mM MgCl 2 , 0.01% gelatin, 0.2 mM each deoxynucleoside triphosphate, 200 ng of each primer, 5 U of Taq DNA polymerase, and 5 ng of pXZ29 plasmid. The amplified DNA fragments were cut with PstI and NcoI and reinserted into pXZ29.
We electroporated competent XE82 cells containing pXZ51 plasmid with plasmids expressing mutagenized CAP and plated them on tetrazolium-lactose plates. As described in Results, only CAP positive-control (pc) mutants for ara p BAD yielded Lac Ϫ red colonies. We purified the plasmids from the red colonies and used them to retransform XE82 and XE64.2/pXZ51 to further verify their CAP pc phenotypes. We sequenced 20 plasmids carrying the mutant CAP gene, and 17 of them possessed only a single nucleotide change.
Protein purification and DNA binding. Wild-type and mutant CAP proteins were purified by cyclic AMP (cAMP) affinity chromatography as described previously (39), yielding proteins more than 95% pure as judged from sodium dodecyl sulfate-acrylamide gel electrophoresis. The DNA binding affinities of these CAP proteins were measured by the DNA migration retardation assay (38) . The 250-bp DNA fragments used in the assay contain ara p BAD , which was amplified from p10ϩCAP by PCR with the primers 5Ј-AATAGGCGTATCAC GAGGCCC-3Ј and 5Ј-GATGGGGAGTAAGCTTGGATTCCAATTGCAATC GC-3Ј. The DNA binding buffer contained 50 mM KCl, 25 mM sodium HEPES (pH 7.4), 2.5 mM MgCl 2 , 2.5 mM dithioerythritol, 100 M cAMP, 100 g of bovine serum albumin per ml, 0.1 mM potassium EDTA, 5% glycerol, and 20 g of calf thymus DNA per ml. CAP was incubated with 0.03 nM labeled araBAD DNA fragments at 37°C for 10 min before the reaction products were subjected to electrophoresis.
RESULTS
CAP can activate the araBAD promoter without the involvement of upstream DNA. DNA upstream of the araBAD promoter participates in transcription repression by DNA looping (9) . The loop is formed when AraC protein binds to the upstream araO 2 and the downstream araI 1 half-sites. CAP helps disrupt the loop to unlock the promoter (27) . It is not known, however, how CAP activates transcription when the araO 2 site has been deleted. One possibility is that AraC uses a hidden upstream binding site or nonspecific DNA and still forms a DNA loop that CAP helps to break. To rule out this possibility, we used just the DNA binding domain of AraC (7). This protein fragment does not dimerize and therefore cannot form a DNA loop. The domain can, however, bind to p BAD , with a special araI 1 * half-site replacing araI 2 . araI 1 * binds AraC considerably more tightly than araI 2 binds AraC (32) . As shown in Fig. 2 , even in this case, CAP still stimulates the araBAD promoter. Apparently this stimulating activity of CAP is independent of AraC-induced DNA looping.
Conceivably, the role of CAP is just to bend DNA so that it will contact the back side of RNA polymerase. This upstream DNA-RNA polymerase interaction could stabilize the transcription complex and enhance the promoter activity. To investigate if this mechanism explains CAP activation at p BAD , we constructed a variation of the araBAD promoter. A second CAP site was placed upstream from the first and positioned so that it bends the DNA away from RNA polymerase. Again, as shown in Fig. 2 To assess possible CAP-AraC interactions in vivo, we compared the amount of AraC binding in the presence and absence of CAP. We performed DMS footprinting at araBAD promoters with and without the CAP binding site. Neither promoter possessed the araO 2 half-site, and thus CAP can stimulate them only directly, not by assisting in loop breaking. If CAP affects the amount of AraC binding, we should be able to detect a difference of AraC footprinting between these two promoters.
In the footprinting assay, cells in the exponential growth phase were treated with DMS. If AraC binds to DNA, two guanines in the AraC binding site become hypersensitive to DMS attack, and the extent of attack correlates well with the occupancy of the site by AraC protein (32) . The left three lanes of Fig. 3 show the footprint of the araBAD promoter lacking the CAP binding site. When arabinose was added, AraC bound DNA and G(Ϫ39) and G(Ϫ60) became hypersensitive to DMS. The right three lanes show the footprint of the araBAD promoter that possesses the CAP binding site. In both the presence and absence of arabinose, the footprint by AraC was the same as on the promoter without the CAP binding site. AraC binding to DNA was not detectably altered by the presence of CAP. We also assayed the activities of the two promoters in vivo and found that the araBAD promoter with the CAP site was about 10 times more active than the one without CAP, even in the absence of arabinose. These results indicate that CAP does not activate transcription by affecting the amount of AraC binding to DNA.
Isolation of crp pc mutants for the araBAD promoter. Having excluded other reasonable possibilities, we considered the possibility that CAP directly interacts with RNA polymerase through protein-protein interactions. If this were the case, we should be able to isolate mutants of CAP defective in the interaction. The desired mutants should still bind DNA normally, however, and could be called pc mutants.
The wild-type araBAD operon is not suitable for the isolation of pc mutants. CAP mutants could disable the arabinose transport operons and lower the arabinose concentration in vivo. This, in turn, would affect induction by AraC and indirectly influence the transcription activity of ara p BAD . Another complication is that the assay of wild-type araBAD operon activity involves the measurement of arabinose metabolism, which again relies on the arabinose transport operons. DNA looping at wild-type p BAD could also mask the CAP pc phenotype. To avoid these indirect effects, we based our selection on plasmid pXZ51 which carries p BAD -araI 1 -araI 1 * fused to lac-ZYA. This variant of the wild-type p BAD promoter possesses a normal basal level and can be activated by CAP to a high level even when AraC is not induced by arabinose (reference 32 and data not shown). This promoter lacks the upstream araO 2 half-site, and thus CAP activates transcription independent of DNA looping. Hence, we completely bypassed DNA looping and the arabinose transporter genes to isolate CAP mutants specifically for ara p BAD . We further characterized our candidates by examining their behavior at two variant ara p BADaraI 1 -araI 1 * promoters, one containing and one lacking a CAP binding site. This latter tests prevents possible confusion from any effects of the CAP mutants on AraC protein expression. For the isolation of CAP pc mutants effective at the araBAD promoter, we used a screen similar to those used previously for the isolation of CAP pc mutants at the lac promoter (40 independent reactions and inserted the mutagenized DNA into CAP-expressing plasmids. We screened 30,000 colonies, of which 270 were Lac Ϫ , and 20 of them yielded Lac Ϫ colonies upon retransformation. As shown in Table 1 , these mutants fall into two groups. The first group includes mutants with mutations from residue 150 to 164 of CAP. This includes AR1 of CAP. Of these mutants, those with His-1593Pro, Gly1623Ser, or Gly-1623Asp have been isolated previously as AR1 mutants (30) . The second group of mutants includes those with changes in amino acids 46 to 68 and 133. These amino acids are in or near the antiparallel ␤-roll region of CAP that contains Lys-52. The amino acids overlap but are not coincident with AR3.
Characterization of the CAP pc mutants. The CAP mutants we isolated repress the p lacUV5 -O CAP promoter as well as wildtype CAP (Table 1) . This indicates that they are not defective in DNA binding, although it is possible that L150P and Q164P owe their reduced activation effects merely to weakened DNA binding. In vivo analysis shows that all these CAP mutants are defective in activating the ara p BAD promoter, in both the presence and absence of arabinose (Table 1) . These results show that the CAP mutants we isolated meet the criteria of pc mutants for p BAD .
The first group of our mutants contains those previously found in the AR1 group. The mutants in this group that have been studied previously affected both class I and class II CAPdependent promoters. Not surprisingly, our mutants were deficient in activating a lac-like class I promoter (data not shown) and CCpmelR (2), a class II promoter.
The mutants in our second group are moderately reduced in their ability to activate the lac-like promoter and the CCpmelR promoter. It has been previously shown that mutations in Lys-52 make CAP more active at class II promoters (2). Table  2 shows that our AR3 mutant, K52E, also activates the CCpmelR promoter fourfold more than wild-type CAP does.
Since most of our second group of mutants have not been previously isolated, we purified three of them and the wild-type CAP protein for further analysis. Their DNA binding affinity to the araBAD promoter was measured by the DNA migration retardation assay. Two mutants bind to DNA as tightly as wild-type CAP does (K d , 50 and 40 nM for L64P and D68G, respectively; K d , 50 nM for the wild type) and K52E binds with about a threefold-lower affinity (K d , 150 nM). We conclude that the DNA binding activities of our mutants are not substantially altered. Figure 4 shows the data for the wild type and the D67G mutant.
Do our pc mutations affect other promoters regulated by AraC or AraC family members? At the araFGH promoter, CAP binds at a site adjacent to RNA polymerase and AraC binds to the upstream site (17, 22) . At the rhaBAD promoter, which is regulated by an AraC family member, RhaR binds immediately adjacent to RNA polymerase and CAP binds upstream from RhaR (11). As Table 2 shows, mutations in AR1 of crp affect both promoters. Interestingly, although the second group of CAP mutants, including the mutant with a mutation at Lys-52, have a large effect at the rhaBAD promoter, these mutations have much less of an effect on activation of the araFGH promoter. 
DISCUSSION
The role of CAP as a coactivator at the araBAD promoter has been investigated in this study. We showed that CAP can stimulate transcription at this promoter in a loop-independent way that does not involve altering AraC DNA binding. We have identified two regions of CAP that are important for activation of the araBAD promoter and the related araFGH and rhaBAD promoters. In light of extensive work by others, our results suggest that CAP directly interacts with RNA polymerase at ara p BAD , ara p FGH , and rha p BAD .
At the araBAD promoter, the AraC protein binding site is centered at position Ϫ52.5 and CAP is centered at position Ϫ93.5. How the CAP protein manages to activate transcription from so far away is not clear. AraC protein represses p BAD transcription by forming a DNA loop, and previous experiments have shown that CAP can help open the repression loop and thereby stimulate promoter activity (15, 27) , but this does not account for all the CAP activation effect.
An attractive model for CAP activation at ara p BAD is that CAP directly interacts with RNA polymerase. This view was cast in doubt, however, when it was reported that the AR1 mutation H159L did not reduce the CAP activation at ara p BAD (37) . This mutation has been shown to disrupt a large number of promoters where CAP directly interacts with RNA polymerase (10) . The confounding study was done with the wild-type araBAD operon, and DNA looping was possible (37) . Hence, substantial CAP activation could have been seen merely as a result of opening the DNA loop. This may have obscured any direct effects of the AR1 mutation. On the other hand, the result did not exclude the possibility that other regions on CAP were responsible for interaction with RNA polymerase at ara p BAD .
We attempted to test the direct-interaction model by isolating CAP mutants defective in transcription activation at ara p BAD but not defective in DNA binding. Interestingly, one group of mutants we isolated had altered residues in or near the activating region one of CAP, AR1. Many lines of evidence have suggested that at class I and II promoters, where CAP is the sole activator, AR1 of CAP interacts with the C-terminal domain of the RNA polymerase alpha subunit (5, 10) . CAP uses this interaction to recruit RNA polymerase to the promoter and increase its initial binding to DNA. The same mechanism probably applies at the araBAD promoter.
If CAP contacts the alpha subunit of RNA polymerase, how does it reach past the interposed AraC protein? If the intervening protein bends the DNA sharply, such an interaction may easily take place. Previous studies have shown that at some promoters with CAP bound around position Ϫ91 and another activator at Ϫ42, AR1 was also required for CAP to activate transcription (6, 23) . Since the C-terminal domain of the alpha subunit is tethered to RNA polymerase through a flexible linker (3, 20) , it is conceivable that this domain can reach over another protein to contact the AR1 of the upstream CAP. At ara p BAD , AraC-induced DNA bending may also help to move the upstream CAP closer to contact RNA polymerase.
The identification of the second group of crp pc mutants at the araBAD promoter was unexpected. The mutations clustered around Lys-52, which is contained in AR3 (5) . A number of amino acid substitutions at Lys-52, including the one we isolated, can improve CAP activation at class II promoters (2) . Also, a previous cross-linking study indicated that Lys-52 is positioned very close to the sigma subunit of RNA polymerase at these promoters (21) . It was suggested that mutations at Lys-52 expose a nonnative activating region that can interact with the RNA polymerase sigma subunit to activate transcription at class II promoters (5) . It is unclear, however, what the role of AR3 at ara p BAD is. Our AR3 mutation K52E reduced CAP activation at p BAD , which could mean that this mutation disrupted an existing activating region of CAP instead of revealing one. Recent studies have indicated that the two alpha subunits of RNA polymerase can each contact upstream activating elements (28) . Possibly, one alpha subunit interacts with AR1 and another interacts with AR3 of CAP. It has also been proposed that at class II promoters, functional AR3 interacts with residues in the region of the sigma subunit from positions 590 to 600 (5) . Previous studies identified sigma mutations at His-596, which made ara p BAD independent of CAP (18), suggesting a sigma-AraC interaction.
A number of the mutations we isolated in the AR3 region are buried inside the protein. These buried amino acids probably cannot contact another protein directly, yet they reduce the CAP activation at p BAD . Perhaps they induce conformational changes in CAP that disrupt the surface-exposed AR1 or AR3 or their accessibilities. We should also point out that residues in this area have been implicated in induction of CAP by cAMP (1) . Recently, a second cAMP pocket was found to exist near the DNA binding domain of CAP (31) . Its occupancy by cAMP or the effects of its occupancy could be affected by our mutations.
It is not surprising that the CAP AR1 mutants that are defective in transcription activation at ara p BAD also affect two related promoters, ara p FGH and rha p BAD . AR1 of CAP probably directly contacts RNA polymerase at these two promoters. Mutations near AR3 only slightly disturb CAP activation at p FGH , however, as might be expected since this is a class II CAP-dependent promoter that also contains upstream AraC binding sites, and AR3 and the surrounding region in wild-type CAP does not directly participate in transcription activation at class II promoters. At the araBAD and rhaBAD promoters, however, mutations in the AR3 region strongly reduce CAP activation. These two promoters both have another activator protein positioned between CAP and RNA polymerase, as opposed to class II CAP-dependent promoters, where CAP binds adjacent to RNA polymerase.
Our results indicate that CAP plays a direct role in transcription activation at ara p BAD . We have demonstrated that CAP can activate ara p BAD without altering DNA looping or AraC binding. A number of CAP pc mutants defective at p BAD were isolated, and they fell into the regions of CAP known to interact with RNA polymerase at many promoters. These lines of evidence suggest that direct CAP-RNA polymerase interactions also occur at ara p BAD .
